Skip to main content
Year archive

Celltrion, Inc. — 2022 filings

All 147 regulatory filings released by Celltrion, Inc. (068270) in 2022, sourced directly from the official regulator.

147 Filings
2022 Period
2022 filings (147)
Filing Released Lang
단일판매ㆍ공급계약체결
Regulatory Filings
2022-12-29 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2022-12-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-28 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount
2022-12-28 Korean
투자판단관련주요경영사항(CT-P13 SC(램시마 피하주사 제형) 미국 품목허가 신청)
Regulatory Filings
2022-12-23 Korean
[기재정정]특수관계인과의내부거래
Director's Dealing
2022-12-16 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2022-12-16 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2022-12-16 Korean
주식배당결정
Notice of Dividend Amount
2022-12-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-12-13 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Audit Report / Information Q3 2022
2022-11-29 Korean
투자판단관련주요경영사항(CT-P13 SC(램시마SC) 임상 3상(궤양성 대장염) 결과 발표)
Regulatory Filings
2022-11-28 Korean
투자판단관련주요경영사항(CT-P13 SC(램시마SC) 임상 3상(크론병) 결과 발표)
Regulatory Filings
2022-11-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-11-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-11-14 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Q3 2022
2022-11-09 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release 9M 2022
2022-11-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-10-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-10-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-10-19 Korean
투자판단관련주요경영사항(항체-약물 접합체(Antibody-drug Conjugate, ADC) 링커-페이로드 플랫폼 기술 실시 옵션 도입 계약 체결)
Regulatory Filings
2022-10-18 Korean
투자판단관련주요경영사항(유플라이마(CT-P17, 휴미라 바이오시밀러) 유럽 상호교환성 임상 3상 시험계획 승인)
Regulatory Filings
2022-10-04 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2022-09-29 Korean
투자판단관련주요경영사항(베그젤마(CT-P16, 아바스틴 바이오시밀러) 미국식품의약국(FDA) 최종 판매 허가 획득)
Regulatory Filings
2022-09-28 Korean
투자판단관련주요경영사항(베그젤마(CT-P16, 아바스틴 바이오시밀러) 국내(MFDS) 품목허가 획득)
Regulatory Filings
2022-09-28 Korean
투자판단관련주요경영사항(HER2 양성 고형암 표적 이중항체 치료 후보물질 'ABP102' 공동 개발 계약 체결)
M&A Activity
2022-09-21 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-09-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-09-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-09-08 Korean
투자판단관련주요경영사항(CT-P43(스텔라라 바이오시밀러) 임상 3상 결과 발표)
Regulatory Filings
2022-09-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-09-02 Korean
[기재정정]신규시설투자등
Regulatory Filings
2022-09-02 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Management Reports
2022-08-30 Korean
투자판단관련주요경영사항(유플라이마(CT-P17, 휴미라 바이오시밀러) 유럽 상호교환성 임상 3상 시험계획 신청)
Regulatory Filings
2022-08-23 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2022-08-19 Korean
투자판단관련주요경영사항(베그젤마(CT-P16, 아바스틴 바이오시밀러) 유럽연합집행위원회(EC) 최종판매허가 획득)
Regulatory Filings
2022-08-19 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
특수관계인에대한주식의처분
Director's Dealing
2022-08-05 Korean
영업(잠정)실적(공정공시)
Earnings Release Q2 2022
2022-08-05 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release H1 2022
2022-08-05 Korean
투자판단관련주요경영사항(유플라이마(CT-P17, 휴미라 바이오시밀러) 미국 상호교환성 임상 3상 시험계획 신청)
Regulatory Filings
2022-08-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-07-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-07-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-07-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-07-29 Korean
자기주식취득결과보고서
Transaction in Own Shares
2022-07-26 Korean
투자판단관련주요경영사항(CT-P47(악템라 바이오시밀러) 유럽 임상 3상 시험계획 승인)
Regulatory Filings
2022-07-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-07-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-07-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-07-06 Korean
투자판단관련주요경영사항(CT-P63+CT-P66(코로나19 흡입형 치료제) 유럽 임상 중단)
Legal Proceedings Report
2022-06-28 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2022-06-28 Korean
투자판단관련주요경영사항(CT-P16(아바스틴 바이오시밀러) 유럽 CHMP(유럽의약품청 산하 약물사용자문위원회) 판매 승인 권고 획득)
Regulatory Filings
2022-06-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-06-24 Korean
투자판단관련주요경영사항(CT-P63+CT-P66(코로나19 흡입형 치료제) 유럽 임상 3상 시험계획 승인)
Regulatory Filings
2022-06-07 Korean
투자판단관련주요경영사항(CT-P47(악템라 바이오시밀러) 미국 임상 3상 시험계획 신청)
Regulatory Filings
2022-06-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-06-02 Korean
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Major Shareholding Notification
2022-05-31 Korean
기업지배구조보고서공시
Governance Information
2022-05-31 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2022-05-24 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares
2022-05-18 Korean
투자판단관련주요경영사항(CT-P47(악템라 바이오시밀러) 유럽 임상 3상 시험계획 신청)
Regulatory Filings
2022-05-17 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
영업(잠정)실적(공정공시)
Earnings Release Q1 2022
2022-05-12 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2022
2022-05-12 Korean
[기재정정]사업보고서 (2016.12)
Audit Report / Information FY 2016
2022-05-12 Korean
[기재정정]사업보고서 (2017.12)
Audit Report / Information FY 2017
2022-05-12 Korean
[기재정정]사업보고서 (2018.12)
Audit Report / Information FY 2018
2022-05-12 Korean
[기재정정]사업보고서 (2019.12)
Audit Report / Information FY 2019
2022-05-12 Korean
[기재정정]사업보고서 (2020.12)
Audit Report / Information FY 2020
2022-05-12 Korean
[기재정정]사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-05-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-29 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2022-04-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-04-20 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-04-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-04-08 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-04-01 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2022-03-30 Korean
자기주식취득결과보고서
Transaction in Own Shares
2022-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-25 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-03-25 Korean
[기재정정]사업보고서 (2021.12)
Regulatory Filings FY 2021
2022-03-17 Korean
기타경영사항(자율공시)
Legal Proceedings Report
2022-03-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-03-08 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2021
2022-03-08 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-08 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-08 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-08 Korean
주주총회집중일개최사유신고
AGM Information
2022-03-08 Korean
투자판단관련주요경영사항(CT-P63+CT-P66(코로나19 흡입형 치료제) 유럽 임상 3상 시험계획 신청)
Regulatory Filings
2022-02-25 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Major Shareholding Notification
2022-02-25 Korean
자기주식취득결과보고서
Transaction in Own Shares
2022-02-21 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares
2022-02-21 Korean
영업(잠정)실적(공정공시)
Earnings Release Q4 2021
2022-02-16 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q4 2021
2022-02-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2021
2022-02-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2022-02-16 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2022-02-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-02-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-01-28 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2022-01-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-01-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-01-13 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares
2022-01-10 Korean